Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Simethicone Excipient

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1BANZEL

    02 5CLOBAZAM

    03 1FELBAMATE

    04 1FLOLIPID

    05 1FYCOMPA

    06 1GRISEOFULVIN

    07 1LOPERAMIDE HYDROCHLORIDE

    08 1PAROXETINE HYDROCHLORIDE

    09 1SULFATRIM

    10 1SULFATRIM PEDIATRIC

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    TARO
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    FELBAMATE

    Drug : FELBAMATE

    Dosage Form : SUSPENSION; ORAL

    Application Number : 206314

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    AMNEAL

    CLOBAZAM

    arrow
    2024 ACI Convention
    Not Confirmed
    AMNEAL
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CLOBAZAM

    Drug : CLOBAZAM

    Dosage Form : SUSPENSION; ORAL

    Application Number : 210039

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    BIONPHARMA

    CLOBAZAM

    arrow
    2024 ACI Convention
    Not Confirmed
    BIONPHARMA
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CLOBAZAM

    Drug : CLOBAZAM

    Dosage Form : SUSPENSION; ORAL

    Application Number : 208819

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    CHARTWELL MOLECULAR

    CLOBAZAM

    arrow
    2024 ACI Convention
    Not Confirmed
    CHARTWELL MOLECULAR
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CLOBAZAM

    Drug : CLOBAZAM

    Dosage Form : SUSPENSION; ORAL

    Application Number : 213110

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    EISAI INC

    RUFINAMIDE

    arrow
    2024 ACI Convention
    Not Confirmed
    EISAI INC
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RUFINAMIDE

    Drug : BANZEL

    Dosage Form : SUSPENSION; ORAL

    Application Number : 201367

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    NOVITIUM PHARMA

    PAROXETINE HYDROCHLORIDE

    arrow
    2024 ACI Convention
    Not Confirmed
    NOVITIUM PHARMA
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PAROXETINE HYDROCHLORIDE

    Drug : PAROXETINE HYDROCHLORIDE

    Dosage Form : SUSPENSION; ORAL

    Application Number : 215003

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    PERRIGO R AND D

    LOPERAMIDE HYDROCHLORIDE

    arrow
    2024 ACI Convention
    Not Confirmed
    PERRIGO R AND D
    Ireland
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    LOPERAMIDE HYDROCHLORIDE

    Drug : LOPERAMIDE HYDROCHLORIDE

    Dosage Form : SUSPENSION; ORAL

    Application Number : 91292

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    PHARM ASSOC

    SULFAMETHOXAZOLE; TRIMETHOPRIM

    arrow
    2024 ACI Convention
    Not Confirmed
    PHARM ASSOC
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    SULFAMETHOXAZOLE; TRIMETHOPRIM

    Drug : SULFATRIM PEDIATRIC

    Dosage Form : SUSPENSION; ORAL

    Application Number : 18615

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    PHARM ASSOC

    SULFAMETHOXAZOLE; TRIMETHOPRIM

    arrow
    2024 ACI Convention
    Not Confirmed
    PHARM ASSOC
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    SULFAMETHOXAZOLE; TRIMETHOPRIM

    Drug : SULFATRIM

    Dosage Form : SUSPENSION; ORAL

    Application Number : 18615

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    SALERNO PHARMS

    SIMVASTATIN

    arrow
    2024 ACI Convention
    Not Confirmed
    SALERNO PHARMS
    Country
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    SIMVASTATIN

    Drug : FLOLIPID

    Dosage Form : SUSPENSION; ORAL

    Application Number : 206679

    Country : US

    Patented : Yes

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF